| Hang Seng Index | 27.080 HKD | +0.080 | +0.296% | 761.80M | 20.63B | 26.730 (+1.311%) HKD as at 2025/09/11 | | |
| Hang Seng China Enterprises | 96.340 HKD | +0.260 | +0.271% | 113.01M | 10.89B | 95.118 (+1.285%) HKD as at 2025/09/11 | | |
| Hang Seng TECH Index | 5.930 HKD | +0.060 | +1.022% | 957.47M | 5.68B | 5.782 (+2.558%) HKD as at 2025/09/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.480 HKD | +0.130 | +2.047% | 178.70M | 1.16B | 6.159 (+5.210%) HKD as at 2025/09/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.280 HKD | -0.028 | -2.141% | 566.55M | 726.51M | 1.353 (-5.409%) HKD as at 2025/09/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.772 HKD | -0.012 | -0.673% | 147.30M | 261.69M | 1.826 (-2.947%) HKD as at 2025/09/11 | | |
| Hang Seng TECH Index | 12.750 HKD | +0.130 | +1.030% | 16.38M | 208.54M | 12.414 (+2.709%) HKD as at 2025/09/11 | | |
| Hang Seng TECH Index | 6.035 HKD | +0.070 | +1.174% | 31.39M | 188.96M | 5.873 (+2.764%) HKD as at 2025/09/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.385 HKD | +0.025 | +0.393% | 24.61M | 156.96M | 6.211 (+2.800%) HKD as at 2025/09/11 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.750 HKD | +0.090 | +0.510% | 7.60M | 134.86M | 17.329 (+2.431%) HKD as at 2025/09/11 | | |
| FTSE China A50 | 16.250 HKD | +0.050 | +0.309% | 5.09M | 82.83M | 16.213 (+0.228%) HKD as at 2025/09/11 | | |
| Hang Seng China Enterprises | 10.790 HKD | +0.010 | +0.093% | 6.04M | 65.12M | 10.745 (+0.421%) HKD as at 2025/09/11 | | |
| CSI 300 | 51.420 HKD | -0.100 | -0.194% | 1.21M | 62.24M | 51.175 (+0.478%) HKD as at 2025/09/12 | | |
| London Gold Fixing Price | 2,611.000 HKD | -2.000 | -0.077% | 13.90K | 36.22M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 7.365 HKD | +0.135 | +1.867% | 4.80M | 35.91M | 7.395 (-0.400%) HKD as at 2025/09/11 | | |
| FTSE US Treasury 20+ Years Index | 70.040 HKD | -0.360 | -0.511% | 501.13K | 35.10M | 70.529 (-0.693%) HKD as at 2025/09/11 | | |
| SSE Science and Technology Innovation Board 50 Index | 12.380 HKD | +0.020 | +0.162% | 1.89M | 23.40M | 12.218 (+1.323%) HKD as at 2025/09/11 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.930 HKD | +0.160 | +1.486% | 2.09M | 22.97M | 10.553 (+3.574%) HKD as at 2025/09/11 | | |
| Hang Seng High Dividend Yield | 30.960 HKD | -0.080 | -0.258% | 735.10K | 22.74M | 30.888 (+0.232%) HKD as at 2025/09/11 | | |
| FTSE China A50 | 15.080 HKD | +0.070 | +0.466% | 1.42M | 21.48M | 15.086 (-0.038%) HKD as at 2025/09/11 | | |
| MSCI China A 50 Connect Index (net total return index) | 28.160 HKD | -0.020 | -0.071% | 580.05K | 16.39M | 28.186 (-0.092%) HKD as at 2025/09/11 | | |
| FactSet China Robotics and Artificial Intelligence Index (net total return) | 59.900 HKD | +0.400 | +0.672% | 248.20K | 14.87M | 58.582 (+2.249%) HKD as at 2025/09/11 | | |
| London Gold Fixing Price | 85.700 HKD | -0.120 | -0.140% | 152.10K | 13.01M | 85.059 (+0.753%) HKD as at 2025/09/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.562 HKD | -0.038 | -1.056% | 3.53M | 12.56M | 3.602 (-1.100%) HKD as at 2025/09/11 | | |
| ChiNext Index | 11.760 HKD | +0.140 | +1.205% | 1.06M | 12.53M | 11.716 (+0.374%) HKD as at 2025/09/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 19.630 HKD | -0.070 | -0.355% | 613.00K | 11.99M | 19.574 (+0.287%) HKD as at 2025/09/11 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.160 HKD | +0.080 | +0.568% | 717.00K | 10.15M | 13.977 (+1.311%) HKD as at 2025/09/11 | | |
| CME Ether Futures | 21.360 HKD | +0.280 | +1.328% | 452.10K | 9.74M | 20.577 (+3.808%) HKD as at 2025/09/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.545 HKD | -0.006 | -1.089% | 15.79M | 8.61M | 0.551 (-1.161%) HKD as at 2025/09/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.748 HKD | +0.004 | +0.084% | 1.52M | 7.29M | 4.819 (-1.479%) HKD as at 2025/09/11 | | |